Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Feb 1:252:80-87.
doi: 10.1016/j.ijcard.2017.10.086. Epub 2017 Oct 31.

Phenotype, management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure

Alexander Van De Bruaene  1 , Edward J Hickey  2 , Adrienne H Kovacs  3 , Andrew M Crean  4 , Rachel M Wald  3 , Candice K Silversides  3 , Andrew N Redington  5 , Heather J Ross  3 , Ana Carolina Alba  3 , Filio Billia  3 , Krishnakumar Nair  3 , Lee Benson  2 , Eric Horlick  3 , Mark Osten  3 , Jack Colman  3 , Jane Heggie  6 , Erwin N Oechslin  2 , S Lucy Roche  7
Affiliations

Phenotype, management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure

Alexander Van De Bruaene et al. Int J Cardiol. .

Abstract

Objective: Although heart failure (HF) is the leading cause of premature death in adult congenital heart disease (ACHD), little population-specific data exist. This study reports early experience from a dedicated, sub-specialty adult congenital heart disease-heart failure (ACHD-HF) clinic, aiming to identify risk factors for adverse outcome.

Methods: Between 2012 and 2015, 126 patients (57% male) attended the ACHD-HF clinic. Baseline and follow-up data were analysed and compared across 4 anatomical/physiological subgroups: cyanotic ACHD, Fontan circulation (1V), biventricular circulation with a subaortic right ventricle (2V-RV) and biventricular circulation with a subaortic left ventricle (2V-LV). Predictors of the composite primary outcome: death, transplant or ventricular assist device (VAD) were identified using multivariable Cox proportional hazard models.

Results: Mean age at first visit was 38±13years. Patients were grouped as follows: cyanotic ACHD 10%, 1V 24%, 2V-RV 29% and 2V-LV 37%. During a median follow-up of 1.7 (IQR 0.8-2.9) years, 38 patients (30%) reached the primary outcome. Event-free survival was 89%, 78% and 63% at 1, 2 and 3years. Forty (31.7%) patients experienced 69 HF hospitalisations. Between-group differences were noted for systolic function, valvular regurgitation, pacing prevalence and invasive hemodynamics. Multivariable analysis revealed 2V-RV subgroup (p=0.001), NYHA class (p=0.002) B-type natriuretic peptide >164pg/ml (p=0.003) and sodium <136mmol/L (p=0.036) as independently associated with death, transplant or VAD.

Conclusions: Our young ACHD-HF patients experienced high adverse event rates during a short period of follow-up. The prognostic markers identified will aid clinicians to stratify short-term risk and thereby guide advanced HF management decisions in ACHD.

Keywords: Adult congenital heart disease; B-type natriuretic peptide; Heart failure; Transplant; Ventricular assist device.

PubMed Disclaimer

LinkOut - more resources